MedTrace Logo

Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER)

NCT04740099 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-10-03

No results posted yet for this study

Summary

Among people at risk of opioid overdose and receiving care in an academic emergency department, family practice, opioid substitution clinic or general inpatient units, does brief opioid overdose resuscitation training and naloxone distribution reduce resuscitation failures in a simulated overdose even, in comparison with standard-of-care referral to a local OEND program, within 14 days post-intervention? Can an integrated participant recruitment and retention strategy recruit approximately 28 eligible participants within 4 weeks and maintain less than 50% attrition rates in the context of a randomized trial on point-of-care OEND and simulated overdose resuscitation performance in family practice, emergency department, and addictions settings?

Conditions

  • Opioid Use
  • Opioid-Related Disorders
  • Opioid Withdrawal
  • Opioid Overdose
  • Education
  • Resusitation

Interventions

OTHER

SOONER Video & Kit

A brief animated video including basic instructions for opioid overdose response accompanied by a Naloxone kit with an info graphic.

OTHER

Standard of Care

A handout including a map and list of locations offering this service.

Sponsors & Collaborators

  • Toronto Public Health

    collaborator OTHER_GOV

  • Ontario College of Art and Design (OCAD)

    collaborator UNKNOWN

  • University of Toronto

    collaborator OTHER

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Carol Strike, PhD · University of Toronto

  • Aaron Orkin, MD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2022-12-31
Completion
2023-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04740099 on ClinicalTrials.gov